H

HD Research LLC | First Surgical Hospital

Research site

(Unclaimed)

Location

4801 Bissonnet Street, Bellaire, Texas, United States of America

Site insights

Top conditions

Top treatments

Acetaminophen

Ibuprofen

Bupivacaine Hydrochloride

Bupivacaine

HTX-011

VX-548

Bupivacaine HCl

CNTX-4975-05

Celecoxib

epinephrine

Parent organization

This site is a part of HD Research LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 21 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling

Crohn's Disease

Drug: Mirikizumab

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.

This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing...

Active, not recruiting

Analgesia

Drug: HTX-011

Drug: Acetaminophen

Phase 2 Pharmacokinetics Study of TLC590 for Postsurgical Pain Management in Multiple Surgical Models

This Phase 2 open-label trial investigates the pharmacokinetics (PK), pharmacodynamics, and safety profile of TLC590 across various surgical procedur...

Not yet enrolling

Postsurgical Pain Management

Drug: Ropivacaine

Drug: TLC590

XG005 for Pain Control in Subjects Undergoing Bunionectomy

This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjec...

Enrolling

Acute Pain

Drug: XG005 tablet

Drug: Placebo tablet